Development of time and pH dependent controlled release colon specific delivery of tinidazole

Daru

Volumn 16, Issue 3, 2008, Pages 119-127

  Naikwade, Sonali R ^a   Kulkarni, Pratibha P ^a   Jathar, Shripad R ^b   Bajaj, Amrita N ^a  

^a SNDT WOMEN S UNIVERSITY   (India)

^b Piramal Enterprises Limited   (India)

Author keywords

Colon specific; Eudragit; Hydroxypropyl methyl cellulose; Time and pH dependent controlled release; Tinidazole

Indexed keywords

EUDRAGIT; FUSIGYN; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER; TINIDAZOLE;

ARTICLE; COLON ABSORPTION; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN EXPERIMENT; LARGE INTESTINE; NORMAL HUMAN; PH; STOMACH EMPTYING; TABLET FORMULATION; TIME;

EID: 50949124167     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Abraham S, Srinath MS. Development of modified pulsincap drug delivery system of metronidazole for drug targeting. Indian J Pharm Sci 2007; 69: 24-27.
2. Hunts PS, Davidson AJL, Alden J, Cheng B. Bile and serum levels of tinidazole after single oral dose. Br J Clinical Pharm 1982; 13: 233-234.
3. Jokipii AMM, Myllyla VV, Jokipii L. Penetration of the blood brain barrier by metronidazole and tinidazole. J Antimicrob Chemother 1977; 3: 239-245.
4. Wust J. Susceptibility of anaerobic bacteria to metronidazole, ornidazole and tinidazole and routine susceptibility testing by standardized methods. J Antimicrob Chemother 1977; 11: 631-637.
5. 14C-tinidazole in humans. J Antimicrob Chemother 1986; 17: 801-809.
6. Hamilton SR. Structure of the colon. Scand. J Gastroenterol 1984; 19: 13-23.
7. MacFarlane GT, Cummings JH. The large intestine: Physiology, pathophysiology and disease In: Philips SF, Pembertion JH, Shorter RJ. The colonic flora, fermentation and large bowel digestive function. New York: Raven Press; 1991. p. 51-88.
8. Libo Y, James SC, Joseph AF. Colon specific drug delivery: new approaches and in vitro/ in vivo evaluation - review. Int J Pharm 2002; 235: 1-15.
9. Krishnaiah Y, Seetha Devi A, Nageswara Rao L, Bhaskar Reddy P, Karthikeyan R, Satyanarayana V. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets. J Pharm Pharmaceut Sci 2001; 4: 235-243.
10. Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 2003; 6: 33-66.
11. Momin M, Pundarikakshudu K. In vitro studies on guar gum based formulation for the colon targeted delivery of sennosides. J Pharm Pharmaceut Sci 2004; 7: 325-331.
12. Naikwade SR, Bajaj AN. Development and evaluation of once a day oral controlled multiparticulate drug delivery systems of cefixime trihydrate. Indian J Pharm Edu Res 2008: (In Press).
13. Wakode R, Bhanushali R, Bajaj A. Development and evaluation of push-pull based osmotic delivery system for pramipexole. PDA J Pharm Sci Tech 2008; 62: (In Press).
14. Naikwade SR, Bajaj AN. Generation of budesonide microparticles by spray drying technology for pulmonary delivery. Indian J Pharm Sci 2007; 69: 717-721 (Proceedings of the symposium on advances in pulmonary and nasal drug delivery, October 2007, Mumbai).
15. Anonymous. The Pharmacopoeia of India, New Delhi: Controller of Publications, 1996.
16. Ahrabi SF, Heinamaki J, Sande SA, Graffner C. Influence of neutron activation factors on matrix tablets for site specific delivery to the colon. Eur J Pharm Sci 2000; 10: 225-235.
17. Fukui E, Miyamura N, Uemura K, Kobayashi M. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int J Pharm 2000; 204: 7-15.
18. Akhgari A, Sadeghi F, Garekani HA. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm 2006; 320: 137-142.
19. Ashford M, Fell J, Attwoods D, Sharma H, Woodhead P. In vivo investigation into the suitability of pH dependant polymers for colonic targeting. Int J Pharm 1993; 95: 193-199.
20. Cummings JH, Banwell JG, Segal I, Coleman N, Englyst HN, MacFarlane GT. The amount and composition of large bowel contents. Gastroenterology 1990; 98: A 408.
21. Friend DR. Colon specific drug delivery. Adv Drug Del Rev 1999; 7: 149-199.
22. Gustafsson DE. The physiological importance of the colonic microflora. Scand J Gastroenterol 1982; 77: 117-131.
23. Simon GL, Gorbach SL. Intenstinal flora in health and diseases. Gastroenterology 1984; 86: 174-193.
24. Anonymous. United States Pharmacopoeia: United States Pharmacopoeial Convention Inc., 2000.